UNSPSC 51294404: Befuraline

This classification denotes a phosphodiesterase inhibitor and antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 787AQ35GHR. European Medicines Agency schedules Befuraline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05683MIG. Befuraline generally arises in the molecular formula C20H20N2O2.

UNSPSC 51294404 Befuraline is a Commodity code that covers pharmaceutical products and chemical compounds used in emergency response and community health initiatives. State and local governments procure naloxone (opioid antagonist medications) and drug deactivation systems under this code, typically through county health departments and emergency management agencies supporting overdose response and substance abuse mitigation programs. Solicitations require vendors to meet standard compliance obligations including drug-free workplace certification, E-Verify employment eligibility verification, and appropriate insurance coverage (workers' compensation, commercial general liability, professional liability). Contracts often include probationary periods and may be subject to federal compliance requirements when funding involves FEMA or other federal sources, including adherence to the Clean Air Act and Federal Water Pollution Control Act. Delivery logistics and shipping costs are typically the vendor's responsibility, with quarterly or other specified delivery schedules to designated public health facilities.

Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The bid deadline was July 26, 2023, at 2:00 p.m., with electronic submission through the county's e-Procurement Portal. The contract structure includes an initial two-year term with an option for a one-year renewal and a three-month probationary period. Recent activity under this code is limited; only one state or local opportunity appears in the current dataset, suggesting either narrow market demand, infrequent procurement cycles, or limited use of this specific UNSPSC classification for naloxone and drug deactivation system procurement.